LOUIS MARC WEINER, M.D.
Medical Practice in Washington, DC
License number
DC MD031312E
Category
Medical Practice
Type
Specialist
Address
Address
3970 NW Lccc Georgetown University Medical Ctr ROOM E501, Washington, DC 20007
Phone
(202) 687-2110
(202) 687-6402 (Fax)
(202) 687-6402 (Fax)
Personal information
See more information about LOUIS MARC WEINER at radaris.comName
Address
Phone
2925 38Th St NW, Washington, DC 20016
Professional information
Dr. Louis M Weiner, Washington DC - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Lombardi Comprehnsv Cncr Ctr
3800 Reservoir Rd NW, Washington 20007
(202) 444-2198 (Phone)
3800 Reservoir Rd NW, Washington 20007
(202) 444-2198 (Phone)
Certifications:
Internal Medicine, 1980, Medical Oncology, 1985
Awards:
Healthgrades Honor Roll
Languages:
English, German
Hospitals:
Lombardi Comprehnsv Cncr Ctr
3800 Reservoir Rd NW, Washington 20007
Fox Chase Cancer Center
333 Cottman Ave, Philadelphia 19111
3800 Reservoir Rd NW, Washington 20007
Fox Chase Cancer Center
333 Cottman Ave, Philadelphia 19111
Education:
Medical School
Mount Sinai School of Medicine
Graduated: 1977
Fletcher Allen Health Care
New England Med Center Hosps
Mount Sinai School of Medicine
Graduated: 1977
Fletcher Allen Health Care
New England Med Center Hosps
Louis M Weiner, Washington DC
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology, Public Health & General Preventive Medicine
Work:
Medstar Georgetown University Hospital
3800 Reservoir Rd NW, Washington, DC 20007
3800 Reservoir Rd NW, Washington, DC 20007
Education:
New York University - Mount Sinai (1977)
Antibodies To Tumor Endothelial Marker 7R
US Patent:
2013005, Mar 7, 2013
Filed:
May 11, 2011
Appl. No.:
13/697024
Inventors:
Hossein Borghaei - King of Prussia PA, US
Louis M. Weiner - Washington DC, US
Louis M. Weiner - Washington DC, US
Assignee:
Fox Chase Cancer Center - Philadelphia PA
International Classification:
C07K 16/30, A61P 35/00, A61K 39/395
US Classification:
4241351, 5303877, 5303873, 5303913, 4241781
Abstract:
Antibodies that specifically bind to an epitope on the extracellular domain of TEM7R are provided. Nucleic acids encoding such antibodies and cells capable of expressing such antibodies are also provided. The antibodies may be used in methods for treating tumors and for inhibiting angiogenesis in tumors.
Combination Therapy Based On Src And Aurora Kinase Inhibition For The Treatment Of Cancer
US Patent:
2011028, Nov 17, 2011
Filed:
Dec 14, 2009
Appl. No.:
13/139441
Inventors:
Vladimir Ratushny - Woodbury NY, US
Erica A. Golemis - Oreland PA, US
Ilya G. Serebriiskii - Rockledge PA, US
Louis M. Weiner - Washington DC, US
Igor Astsaturov - Philadelphia PA, US
Andrew Godwin - Jenkintown PA, US
Erica A. Golemis - Oreland PA, US
Ilya G. Serebriiskii - Rockledge PA, US
Louis M. Weiner - Washington DC, US
Igor Astsaturov - Philadelphia PA, US
Andrew Godwin - Jenkintown PA, US
International Classification:
A61K 31/506, A61K 31/713, A61P 35/00, A61K 31/55
US Classification:
514 44 A, 51425219, 514215
Abstract:
Compositions which act synergistically to inhibit the growth of cancer cells and methods of use thereof are disclosed.
Egfr/Nedd9/Tgf-Beta Interactome And Methods Of Use Thereof For The Identification Of Agents Having Efficacy In The Treatment Of Hyperproliferative Disorders
US Patent:
2013033, Dec 12, 2013
Filed:
Jul 15, 2013
Appl. No.:
13/942032
Inventors:
Erica A. Golemis - Oreland PA, US
Ilya G. Serebriiskii - Rockledge PA, US
Louis M. Weiner - Washington DC, US
Ilya G. Serebriiskii - Rockledge PA, US
Louis M. Weiner - Washington DC, US
Assignee:
Fox Chase Cancer Center - Jenkintown PA
International Classification:
G01N 33/50
US Classification:
506 10
Abstract:
Compositions and methods for the treatment and diagnosis of cancer are disclosed.
Egfr/Nedd9/Tgf-Beta Interactome And Methods Of Use Thereof For The Identification Of Agents Having Efficacy In The Treatment Of Hyperproliferative Disorders
US Patent:
2010023, Sep 23, 2010
Filed:
May 10, 2010
Appl. No.:
12/777112
Inventors:
Igor Astsaturov - Philadelphia PA, US
Erica A. Golemis - Oreland PA, US
Ilya G. Serebriiskii - Rockledge PA, US
Louis M. Weiner - Washington DC, US
Erica A. Golemis - Oreland PA, US
Ilya G. Serebriiskii - Rockledge PA, US
Louis M. Weiner - Washington DC, US
International Classification:
A61K 39/395, A61K 31/517, A61K 31/713, A61K 9/127, A61K 31/277, A61K 31/5377, A61K 31/4545, A61K 31/4045, A61P 35/00, G01N 33/574, C12Q 1/68
US Classification:
424450, 4241451, 5142664, 514 44 A, 514523, 5142345, 51426624, 514318, 514414, 435 723, 435 6
Abstract:
Compositions and methods for the treatment and diagnosis of cancer are disclosed.
Anti-Egfr Family Antibodies, Bispecific Anti-Egfr Family Antibodies And Methods Of Use Thereof
US Patent:
8580263, Nov 12, 2013
Filed:
Nov 20, 2007
Appl. No.:
12/515522
Inventors:
Gregory P. Adams - Hatboro PA, US
Eva M. Horak - West Oragne NJ, US
Louis M. Weiner - Washington DC, US
James D. Marks - Kensington CA, US
Eva M. Horak - West Oragne NJ, US
Louis M. Weiner - Washington DC, US
James D. Marks - Kensington CA, US
Assignee:
The Regents of the University of California - Oakland CA
Fox Chase Cancer Center - Philadelphia PA
Fox Chase Cancer Center - Philadelphia PA
International Classification:
A61K 38/00
US Classification:
4241431, 4241361, 4241551, 5303871, 5303877, 53038822
Abstract:
Anti-EGFR family member antibodies and bispecific antibodies comprising one or more anti-EGFR family member antibodies are disclosed. These antibodies can be used to advantage to specifically target forms of cancer associated with the overexpression of members of the EGFR protein family.
Bispecific Single Chain Fv Antibody Molecules And Methods Of Use Thereof
US Patent:
2013020, Aug 8, 2013
Filed:
Dec 10, 2012
Appl. No.:
13/710146
Inventors:
The Regents of the University of California - Oakland CA, US
Fox Chase Cancer Center - Philadelphia PA, US
Louis M. Weiner - Washington DC, US
James D. Marks - Kensington CA, US
Fox Chase Cancer Center - Philadelphia PA, US
Louis M. Weiner - Washington DC, US
James D. Marks - Kensington CA, US
Assignee:
Fox Chase Cancer Center - Philadelphia PA
The Regents of the University of California - Oakland CA
The Regents of the University of California - Oakland CA
International Classification:
A61K 39/395
US Classification:
4241351
Abstract:
Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
Combination Therapy For The Treatment Of Cancer
US Patent:
2011003, Feb 10, 2011
Filed:
Mar 12, 2009
Appl. No.:
12/922310
Inventors:
Vladimir Ratushny - Woodbury NY, US
Erica Golemis - Oreland PA, US
Igor Astsaturov - Philadelphia PA, US
Iiya G. Serebriiskii - Rockedge PA, US
Louis M. Weiner - Washington DC, US
Erica Golemis - Oreland PA, US
Igor Astsaturov - Philadelphia PA, US
Iiya G. Serebriiskii - Rockedge PA, US
Louis M. Weiner - Washington DC, US
International Classification:
A61K 39/395, A61K 31/713, A61K 31/55, A61K 31/496, A61K 31/517, A61K 31/5377, A61K 38/47, A61K 38/16, A61K 31/675, A61K 33/24, A61K 31/573, A61K 38/46, A61K 31/706, A61K 31/568, A61K 31/7072, A61K 31/565, A61K 31/57, A61K 38/08, A61P 35/00, A61P 35/04, A61K 38/09
US Classification:
4241331, 4241421, 514 44 A, 514215, 51425219, 51425406, 5142664, 5142338, 424 9461, 514 193, 514 198, 514 90, 424649, 514177, 424 946, 514 43, 514178, 514 50, 514171, 514 97, 514 194, 514 195, 514 104, 514 103
Abstract:
Compositions which act synergistically to inhibit the growth of cancer cells and methods of use thereof are disclosed.